Pharmacy review for VIC workers' compensation
Medication management aligned with WorkSafe Victoria and return-to-work priorities
Published: 3 April 2026 | Updated: 3 April 2026
Victoria's workers' compensation context
Victoria's workers' compensation system, regulated through WorkSafe Victoria, emphasizes early return to work and rehabilitation. This creates a different pressure point for medication management compared to other states. Medications that support early recovery and work participation are prioritized; medications that impede return-to-work or create dependence are actively managed.
Your medication strategy in VIC claims should align with these principles. Medications should support rehabilitation and work participation. Those that don't should be questioned or changed.
VIC emphasis: WorkSafe Victoria prioritizes early intervention and return-to-work outcomes. Medication reviews should identify where medications are supporting or hindering work participation. A medication that controls pain but prevents work is questionable; one that enables work participation is justified.
Medication and return-to-work: the critical link
In Victoria, medication decisions should be evaluated against return-to-work objectives:
- Does this medication enable the claimant to participate in rehabilitation? Pain control that allows physiotherapy is valuable. Sedation that prevents engagement is problematic
- Does this medication enable work participation or trial? If the claimant can't return to modified duties or a work trial because medication side effects are too severe, medication optimization is needed
- Is medication dependence preventing recovery? Long-term benzodiazepines or opioids that the claimant becomes dependent on are counterproductive to recovery goals
- Could deprescribing improve work capacity? Reducing sedating medications often improves cognition and motivation, enabling better work participation
These questions drive medication review in the VIC context.
When to refer for a pharmacy review in VIC claims
Early intervention (within first 6-12 weeks)
If medication patterns are already problematic (e.g., benzodiazepines being prescribed for acute anxiety; high-dose opioids early), refer for review to establish good early practices and prevent entrenchment of problematic medications.
Return-to-work planning (3-6 months)
Before initiating return-to-work activities, review medications for any that would impair work participation. If cognitive side effects, sedation, or safety concerns exist, optimize medications before the claimant engages in work activities.
Work trial or return phase (6-12 months)
If the claimant struggles during work trial or has difficulty with work tasks, ask whether medications are contributing. Cognitive impairment, fatigue, or reduced motivation often trace back to medication effects. Review and optimize before adjusting work tasks.
Long-term claim management (12+ months)
As claims extend beyond 12 months, medication patterns should be reviewed regularly. Long-term benzodiazepines or opioids should be actively managed with deprescribing plans. Medications should be rationalized to essential agents only.
VIC-specific assessment framework
Medication assessment aligned with return-to-work
When reviewing medication in a VIC claim, evaluate:
- Clinical necessity: Is this medication still needed for the injury condition? Has the clinical indication changed?
- Work capacity impact: Does this medication improve or impair the claimant's ability to participate in work or work-related activities?
- Rehabilitation engagement: Is the claimant attending therapy appointments and engaging in rehabilitation, or are medications limiting participation?
- Dependence risk: Is there risk of medication dependence that would complicate future deprescribing and recovery?
- Cost alignment with outcomes: Is the cost of medication proportionate to its contribution to recovery and work participation?
Common VIC scenarios requiring medication review
Acute injury with early benzodiazepine prescription
Scenario: A worker with acute anxiety post-injury is prescribed benzodiazepines. Within weeks, the question arises: should this be ongoing?
VIC approach: Assess whether benzodiazepines are still needed or whether transitioning to psychological support (cognitive behavioral therapy for anxiety) would better serve recovery and return-to-work. Benzodiazepines may be appropriate for 2-4 weeks acutely, but ongoing use complicates return-to-work. Early pharmacist review can establish deprescribing plans before dependence develops.
Chronic pain management impeding work participation
Scenario: A claimant with chronic lower back injury is on opioids and benzodiazepines. Pain is controlled, but the claimant is too sedated to attempt work trial.
VIC approach: Medication review identifies that sedation is the limiting factor. Opioid dose reduction or shift to non-opioid pain management, coupled with benzodiazepine cessation, may restore work capacity. The pharmacist works with the pain team to optimize analgesia while restoring function. This directly supports return-to-work goals.
Medication side effects blocking rehabilitation participation
Scenario: A claimant is scheduled for intensive physiotherapy to improve function, but medication side effects (cognitive impairment, fatigue) are limiting engagement.
VIC approach: Medication optimization is necessary before proceeding with rehabilitation. The pharmacist assesses which medications are contributing to side effects, recommends dose adjustments or alternatives, and supports improved participation. This is a prerequisite for effective rehabilitation, not a parallel intervention.
Deprescribing as a recovery tool in VIC
In the VIC context, deprescribing is often a recovery tool, not just a cost-saving measure. Structured deprescribing of medications that have become unnecessary or are hindering recovery supports return-to-work objectives. Key principles:
- Early planning: Begin deprescribing discussions early, before long-term dependence develops
- Concurrent support: Provide psychological support, rehabilitation intensification, or alternative management during deprescribing
- Alignment with return-to-work: Use deprescribing as an opportunity to restore cognition, motivation, and function needed for work
- Clear communication: Explain to the claimant that deprescribing is part of recovery, not punishment or withdrawal of support
Medication cost management in VIC claims
WorkSafe Victoria focuses on reasonable costs for reasonable treatment. Cost management includes:
- PBS preference: Use PBS-listed medications where appropriate before approving more expensive alternatives
- Generic prescribing: Request prescribers use generic names to enable cheaper generic dispensing
- Regular audits: Question large invoices and request itemization and justification
- Deprescribing long-term medications: Reduce ongoing costs through structured medication reduction
- Consolidation: Ensure the claimant uses one pharmacy for better oversight and to identify and eliminate duplication
Documentation and reporting in VIC claims
When documenting medication decisions in VIC claims, include:
- Return-to-work status: Is the claimant engaged in rehabilitation or work trial? How are medications supporting or hindering this?
- Clinical justification: Why is each medication necessary for the compensable injury? How does it support recovery?
- Cost-benefit analysis: Is the cost of medication proportionate to its contribution to recovery and work participation?
- Medication review findings: What was recommended, what actions were taken, what was the outcome?
- Deprescribing plans: For long-term medications, what is the plan to reduce or cease them?
Coordination with case management
In VIC claims, pharmacy review works closely with case management. The case manager tracks rehabilitation and return-to-work progress; the pharmacist manages medications supporting that progress. Communication between these teams is essential:
- Case manager identifies obstacles to return-to-work; pharmacist assesses whether medication is contributing
- Pharmacist identifies medications limiting function; case manager coordinates rehabilitation or work trial adjustments
- Joint effort to deprescribe long-term medications while coordinating alternative support
Timeline and milestones in VIC claims
| Claim Stage | Return-to-Work Goal | Medication Review Focus |
|---|---|---|
| Acute (0-6 weeks) | Pain/symptom control; initial rehabilitation | Establish appropriate medications; prevent early benzodiazepine dependence; plan early deprescribing |
| Early subacute (6-12 weeks) | Rehabilitation engagement; modified duties trial planning | Review medications for rehabilitation barriers; optimize for work participation; begin deprescribing short-term medications |
| Late subacute (3-6 months) | Return-to-work trial; full capacity planning | Ensure medications support work capacity; address any side effects limiting work participation |
| Early chronic (6-12 months) | Sustained work participation; sustainable recovery | Rationalize medications to essential agents; begin deprescribing long-term medications; establish maintenance regimen |
| Late chronic (12+ months) | Full work participation; minimal ongoing support | Annual review; minimize medication burden; coordinate transition of permanent medications to private/Medicare |
Key principles for VIC medication management
- Medication should support return-to-work and rehabilitation, not hinder it
- Early intervention prevents long-term medication patterns
- Deprescribing is a recovery tool, not just cost reduction
- Cognitive side effects and sedation that block work are red flags requiring urgent medication review
- Benzodiazepines and long-term opioids should be actively managed with deprescribing plans
- Cost should be proportionate to contribution to work capacity and recovery
Working with IMM on VIC claims
IMM provides medication reviews aligned with VIC return-to-work objectives:
- Assessment of how medications support or hinder work participation
- Recommendations for medication optimization to improve work capacity
- Deprescribing planning aligned with rehabilitation milestones
- Collaboration with case managers and treating teams to coordinate medication changes with return-to-work activities
- Documentation supporting WorkSafe expectations for reasonable cost and effective treatment
Medication hindering return-to-work in your VIC claim?
IMM provides focused medication reviews that align with VIC return-to-work principles. We identify how medications are supporting or blocking recovery, recommend optimization, and support deprescribing aligned with rehabilitation milestones.
Request a Medication Review
